Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal/Gastroesophageal Junction Adenocarcinoma (PHOX)

NCT06078709 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06078709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal/Gastroesophageal Junction Adenocarcinoma (PHOX)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
November 21, 2023
Completion date
May 25, 2029
Enrollment
99 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage i esophageal adenocarcinoma ajcc v8, clinical stage i gastroesophageal junction adenocarcinoma ajcc v8, clinical stage ii esophageal adenocarcinoma ajcc v8, clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8